Andrew Hollman Meyer, Chief Business Officer: Janux Therapeutics JANX Sell · Filed 01/02

Trade details

Type: Insider sale
Amount: $25,798.67
Shares · price: 1,879 sh · $13.73 a share
Held after: 83,095 sh
Stock: Janux Therapeutics JANX
Person: Andrew Hollman MeyerChief Business Officer
Trade date: 26/01/02
Filed: 26/01/02
Days to filing: 0 days

Sold 2.2% of holdings

Share of holding sold: 2.2%

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/03~02/01

Andrew Hollman Meyer's recent trades

Andrew Hollman MeyerChief Business Officer
Planned saleJanux Therapeutics
Planned sale
Janux Therapeutics
JANX
$28.2K
1,877 sh
$28.2K
Filed 04/13
Traded 04/13
Andrew Hollman MeyerChief Business Officer
Planned saleJanux Therapeutics
Planned sale
Janux Therapeutics
JANX
$2.6M
178,767 sh
$2.6M
Filed 01/26
Traded 01/26
Andrew Hollman MeyerChief Business Officer
Planned saleJanux Therapeutics
Planned sale
Janux Therapeutics
JANX
$1.7M
118,122 sh
$1.7M
Filed 01/23
Traded 01/23
Andrew Hollman MeyerChief Business Officer
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$88.7K
2,700 sh
$88.7K
Filed 25/12/03
Traded 25/12/01
Andrew Hollman MeyerChief Business Officer
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$21.2K
633 sh
$21.2K
Filed 25/12/03
Traded 25/12/01